||EPS - Basic
||Market Cap (m)
Provexis Share Discussion Threads
Showing 45876 to 45898 of 45900 messages
|nothing to see here deleted.|
I asked you at the time,I think,which you thought would be better and I said " You're going to answer both" but I can't remember what you answered.|
|Fried mars bar (in oil), is weird but, but consumed.|
|Why not, you can get salted caramel?|
" ... which contributes to normal blood flow"
Far be it from me to interrupt your playground nonsense on the blue channel, but even you might see that if flavanols do the above, then to the average consumer, they're in the same market.
Peppa, you're wrong IMO. I guess it will be FAR easier to get people to take a pill from chocolate than one from tomatoes. I know which I'd prefer.
Reality check: the combination of reduced platelet activation plus increased vessel elasticity, might be synergistic.
Mars bar with a dash of tomato sauce anyone? Bernie?|
|Hopefully get the funding news out of the way this week ,then we can move forward after a trading update next month|
|I looked it up and found that it was already covered-had forgotten
|I would not worry about that, I am co-designer on several patents and received a one off invention fee and no ongoing royalties, depends if work is paid for by PXS in which case they own the rights to the fruit of this work.|
|So presumably they will get some kind of payment from PXS?
Sorry to complicate things-maybe doesn't really matter|
|Patent for blood pressure bit is part owned by oslo university is it not?|
|READ THIS CAREFULLY.
Provexis Signs Memorandum Of Understanding For China Product Research
[ 06 Apr 2017 10:43 ]
LONDON (Alliance News) - UK ingredients company Provexis PLC said on Thursday it has signed a Memorandum Of Understanding with Chinese dietary supplement business By Health Company Ltd, intended to result in a research and collaboration agreement for Provexis' tomato-extract product, Fruitflow.
Provexis and its Alliance partner, DSM Nutritional Products will also be working with By-Health to launch Fruitflow-based products into the Chinese market, starting in the second half of 2017.
The proposed research and collaboration agreement is to be signed later this year, and the resulting research programme is scheduled for completion in 2018.
Under the MoU, Provexis and By Health will provide primary funding for By-Health's research programme, focusing on the development of new products that contribute towards cardiovascular health, particularly blood pressure regulation.
Any products covered under Provexis' existing patents will be wholly owned by them, and Provexis will hold joint ownership over any new products developed as part of the programme.
"The company's Fruitflow technology is well placed to address the large and growing issue of cardiovascular health in China, and the MOU announced today and planned launch by By-Health of some Fruitflow based products in China are strongly Positive developments for Fruitflow and the Provexis business," Chairman of Provexis Dawson Buck said.
Shares in Provexis were up by 16% at 0.625 pence on Thursday morning.
By Dayo Laniyan; email@example.com
I feel suitably chastised !|
|This is a very long term investment and hold. It could be at least 5 years before we see any real progress here in the share price. Profits need to be made !. Whilst this is very speculative and risky should this take off one day the rewards will follow. I have a modest holding here 1m shares . Only time will tell|
|Bernie, I think you're missing the point somewhat. See what I did there? :)
We need dietary supplement clinical evidence first to then justify pharmaceutical interest later on. Basically it's one step at a time. Frustrating to think we could have done the ground work years ago.
If PXS control future IP development, as we have with WSTC, it will justify a significant valuation in due course.|
|lol, By-health has been on my radar for a while, things work differently in China and the rumours can go for a while prior to decisions and agreements being made leading to news. of course I'm giddy, but then I have nice low average price showing profit ~;-)|
|Been predicted successful for outside the country.|
It's good news, but By-Health ain't Pharma mate, they're dietary supplements so the BP work is likely to be an extension of what's already been done rather than the start of a pharma inspired piece of work
LOL@SS getting all giddy :)
Having said that, if the work with By-Health leads to something commercially viable, this might be the beginning of the end of PXS, but it's a long way off that at the moment.
|Re, AGL, I'm holding.......|
|Libra, I think this has more legs in it in short term, let's hope they fundraise or place share with By-Health at over 1p. I'm of the mind to keep share longer term though, direction and strategy of the company much more to my liking.|
|Some firms do placings to take advantage of spikes in the share price Let's see how bright our BoD is.|
|SS; nice and early'ish start for me today. :) Thoughts on AGL and FDI?
Personally, I think today's news is probably the best possible. It allays fears of significant fund raising for now yet gives hope of tangible pharmaceutical interest in due course.
There'll likely be a small fundraising soon but money for R&D will come, hopefully, once we're profitable.
Thoughts RP and Bernie?|